Your browser doesn't support javascript.
loading
Anlotinib in Locally Advanced or Metastatic Radioiodine-Refractory Differentiated Thyroid Carcinoma: A Randomized, Double-Blind, Multicenter Phase II Trial.
Chi, Yihebali; Zheng, Xiangqian; Zhang, Yuan; Shi, Feng; Cheng, Ying; Guo, Zhuming; Ge, Minghua; Qin, Jianwu; Zhang, Jiewu; Li, Zhendong; Zhou, Xiaohong; Huang, Rui; Chen, Xiaohong; Liu, Hui; Cheng, Ruochuan; Xu, Zhengang; Li, Dapeng; Tang, Pingzhang; Gao, Ming.
Afiliación
  • Chi Y; Department of Medical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Zheng X; Department of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Zhang Y; Department of Head and Neck Surgery, Jiangsu Cancer Hospital (Jiangsu Institute of Cancer Research, Nanjing Medical University Affiliated Cancer Hospital), Nanjing, China.
  • Shi F; Thyroid Tumour Internal Medicine Department/Nuclear Medicine Center, Hunan Cancer Hospital, Changsha, China.
  • Cheng Y; Department of Medical Oncology, Jilin Cancer Hospital, Changchun, China.
  • Guo Z; Head and Neck Surgery, Sun Yat-sen University Cancer Center, Guangzhou, China.
  • Ge M; Head and Neck Surgery, Institute of Cancer and Basic Medicine (ICBM), Chinese Academy of Sciences; Cancer Hospital of the University of Chinese Academy of Sciences; Zhejiang Cancer Hospital, Hangzhou, China.
  • Qin J; Head and Neck Surgery, Zhejiang Provincial People's Hospital, People's Hospital of Hangzhou Medical College, Hangzhou, China.
  • Zhang J; Thyroid & Head and Neck Surgery, Affiliated Cancer Hospital of Zhengzhou University, Henan Cancer Hospital, Zhengzhou, China.
  • Li Z; Department of Head and Neck Surgery, Harbin Medical University Cancer Hospital, Harbin, China.
  • Zhou X; Department of Head & Neck Surgery, Liaoning Tumor Hospital, Shenyang, China.
  • Huang R; Head and Neck Cancer Center, Chongqing University Cancer Hospital, Chongqing Cancer Hospital, Chongqing, China.
  • Chen X; Nuclear Medicine, West China Hospital, Sichuan University, Chengdu, China.
  • Liu H; Department of Otolaryngology Head and Neck Surgery, Beijing Tongren Hospital, Capital Medical University / Key Laboratory of Otolaryngology Head and Neck Surgery, Ministry of Education, Beijing Institute of Otolaryngology, Beijing, China.
  • Cheng R; Head and Neck Surgery, Fujian Cancer Hospital, Fuzhou, China.
  • Xu Z; Department of Thyroid Surgery, First Affiliated Hospital of Kunming Medical University, Kunming, China.
  • Li D; Head and Neck Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
  • Tang P; Department of Thyroid and Neck Oncology, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer; Key Laboratory of Cancer Prevention and Therapy, Tianjin; Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Gao M; Department for VIP, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, China.
Clin Cancer Res ; 29(20): 4047-4056, 2023 Oct 13.
Article en En | MEDLINE | ID: mdl-37594724

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo: 1 Base de datos: MEDLINE Tipo de estudio: Clinical_trials Idioma: En Revista: Clin Cancer Res Asunto de la revista: NEOPLASIAS Año: 2023 Tipo del documento: Article País de afiliación: China